Epitope Discovery via Nanocluster Presentation
Epitope Discovery via Nanocluster Presentation
批准号:
7582398
负责人:
DAVID E CLIFFEL
金额:
$27.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2011-02-28
关键词:
AntibodiesAntigensBiologyChildhoodCommunicable DiseasesDevelopmentDiagnosticEmerging Communicable DiseasesEngineeringEpitopesFaceFoundationsFutureGenerationsGoalsGoldHumanImmune systemImmunologistImmunotherapyInstitutesKnowledgeLabelLibrariesMedicineMethodsMolecular ConformationMusNanostructuresNanotechnologyPatientsPeptidesProteinsRecombinantsResearchResearch PersonnelScreening procedureSerumStructureSurfaceTechnologyToxinVaccinesWorkanthrax protective factorbasedesignimmunogeniclaboratory facilitymicroorganismmolecular recognitionnanobiotechnologynanomedicinenanoparticlenovelnovel strategiespathogenpeptide structureprotein structureresponsescaffoldsynthetic proteinvaccine candidate
中文摘要
这项建议的目的是开发一个多功能的纳米颗粒平台,用于展示表位
具有免疫学分析的金纳米簇,用于创建针对免疫的纳米技术
系统。基于纳米颗粒的疫苗的未来发展需要产生蛋白质
如实概括病原微生物保护性抗原构象的结构。
具有讽刺意味的是,我们逻辑地设计具有保护性的重组或合成蛋白抗原的能力相当强
有限的。由于天然蛋白质上的大多数表位可能是组装的,最重要的是
表位确定工作面临的挑战是识别构象组装的表位。
我们假设靶蛋白质环结构在金纳米团簇表面的呈现
将呈现统计上显著的潜在环状构象的多样性,从而为
发现致病毒素未知表位的新方法。为了证明这一点的可行性
方法,我们正在创建一个模拟芽孢杆菌保护性抗原(PA)的表位标记的纳米簇
炭疽病。在这个提案中,我们的目标是提炼和扩展我们的表位概念策略
通过以下具体目标介绍纳米集群:
1.设计、合成和组装金表面的线性和构象表位
纳米团簇。
2.确定哪一种构象肽环结构忠实地代表自然产生的
天然蛋白质中的免疫原性结构。
3.使用纳米簇上呈现的表位筛选小鼠和人类抗体库,以及患者血清
致力于开发诊断微阵列。
4.优化多功能纳米粒对小鼠的免疫应答。
纳米技术中的具体挑战将是在纳米颗粒上创建特定的亚结构
表面,这些特定构象的免疫识别,多功能纳米颗粒的创建,以及
多肽环结构与纳米颗粒大小和曲率的关系。中的具体变化
生物学和医学包括发现未映射的线性和构象表位,免疫表位
系统对功能化纳米颗粒的反应,构象抗体库的筛选
表位,以及最终向构象表位标记纳米粒子的潜在发展
疫苗。
英文摘要
The purpose of this proposal is to develop a multifunctional nanoparticle platform for epitope presentation on
gold nanoclusters with immunological analysis for the creation of nanotechnologies that target the immune
system. The future development of nanoparticle-based vaccines requires the generation of protein
structures that faithfully recapitulate the conformation of protective antigens of pathogenic microorganisms.
Ironically, our ability to logically design recombinant or synthetic protein antigens that are protective is quite
limited. As most epitopes on native proteins are likely to be assembled, one of the most significant
challenges facing epitope determination efforts is the identification of conformationally assembled epitopes.
We hypothesize that the presentation of target protein loop structures on the surface of gold nanoclusters
will present a statistically significant diversity of potential loop conformations to provide the foundation of a
new method for discovering unknown epitopes of pathogenic toxins. To demonstrate the feasibility of this
approach, we are creating an epitope-labeled nanocluster that mimics the protective antigen (PA) of Bacillus
anthracis. In this proposal, our goal is to refine and extend our conceptual strategies for epitope
presentation on nanoclusters via the following specific aims:
1. Design, synthesize, and assemble linear and conformational epitopes on the surface of gold
nanoclusters.
2. Determine which of the conformational peptide loop constructs faithfully represent the naturally occurring
immunogenic structures in native protein.
3. Screen mouse and human antibody libraries, and patient sera using epitopes presented on nanoclusters
working towardsthe development of a diagnostic microarray.
4. Optimize the immunological response of multifunctional nanoparticles in mice.
Specific challenges in nanotechnology will be the creation of specific substructures on a nanoparticle
surface, immunorecognition of these specific conformations, creation of multifunctional nanoparticles, and
correlation of peptide loop structure as a function of nanoparticle size and curvature. Specific changes in
biology and medicine include the discovery of unmapped linear and conformational epitopes, the immune
system response to functionalized nanoparticles, the screening of antibodies libraries for conformational
epitopes, and ultimate development towards conformational epitope-labeled nanoparticles as potential
vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Potentiating Psilocybin
-
批准号:10354547
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2022
-
负责人:DAVID E CLIFFEL
-
依托单位:
Potentiating Psilocybin
-
批准号:10602394
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2022
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10037372
-
项目类别:
-
资助金额:$66.29万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10651647
-
项目类别:
-
资助金额:$61.85万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10430227
-
项目类别:
-
资助金额:$63.11万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
Instrumenting the Fetal Membrane on a Chip
-
批准号:10249282
-
项目类别:
-
资助金额:$63.72万
-
财政年份:2020
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:8575127
-
项目类别:
-
资助金额:$29.15万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:8734456
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:8883627
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
The Fisk-Vanderbilt Biomedical Bridge to the Doctorate
-
批准号:9274302
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2013
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7783751
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7909868
-
项目类别:
-
资助金额:$1.24万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7026629
-
项目类别:
-
资助金额:$28.24万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7383845
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
Epitope Discovery via Nanocluster Presentation
-
批准号:7186717
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2006
-
负责人:DAVID E CLIFFEL
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: